Alucent Biomedical has filed a notice of an exempt offering of securities to raise $11,200,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Alucent Biomedical is raising $11,200,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Myles Greenberg played a…
